Almost 170,000 sample packs of Taytulla birth control pills are being recalled because placebo and active capsules were packaged out of order, increasing the risk of unwanted pregnancy. The sample packs were distributed to physicians across the US.
According to the FDA recall notice, Allergan recently identified — through a physician report — that four placebo capsules were placed out of order in a sample pack of Taytulla. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.
The affected lot numbers and photos of the product are available from the FDA recall notice. Allergan is notifying customers by recall letter and advising women who have used a Taytulla sample pack from the recalled lot to consult with their physician.
Health care professionals are encouraged to report adverse events or side effects to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
About the Author
Laura Hale Brockway is Assistant Vice President of Marketing at TMLT and has more than 17 years of experience in communications, 15 of those years with TMLT. Ms. Brockway has also worked for Seton Healthcare Family and the Texas Academy of Family Physicians. An honors graduate of the University of Texas at Austin, Ms. Brockway holds an Editor in Life Science (ELS) certification from the Board of Editors in the Life Sciences. She is also a contributor to Ragan Communication’s PR Daily website and is the author of the blog, impertinentremarks.com. Laura Brockway can be reached at email@example.com.More Content by Laura Hale Brockway